DeviceClearance

K221813

Substantially Equivalent

Nova Allegro UACR Assay, Nova Allegro Analyzer

Applicant
Nova Biomedical Corporation
Product code
CGX
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Dual Track
Location
Walham, MA, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.